Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Sciterion Logo

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

- PMLiVE

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Clinical Research, Market access, Pharmacy

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Kantar Health
11 Madison Avenue, 12th Floor, New York, NY, 10010, USA
1-212-647-7200
Contact Kantar Health
Website

 Latest Content from PMHub 

Why stigma is a launch risk in rare disease – and what commercial leaders can do about it

White Papers and Resources | March 2, 2026 | Havas Life London

Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.

From ‘why’ to ‘how’: patient partnership across age groups in research and publications

White Papers and Resources | February 27, 2026 | Amiculum

By Sarah Mohamad

From Static to Strategic: The 2026 Playbook for Longitudinal Pharma Interaction

Press Releases | February 26, 2026 | Impetus Digital

Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 Engagement Toolkit—a deep dive into the immersive, longitudinal strategies and newly...

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

Press Releases | February 25, 2026 | Medscape Education

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...

T40: when a number is not just a number

Press Releases | February 23, 2026 | Grace Communications

Proud to be ranked 3rd among the Top 10 UK-focused agencies, along with other categories, Grace Communications finds inspiration in being included in PMLive’s Top 40 Creative Healthcare Agencies 2025.

Why patient engagement must come first in rare disease trials

White Papers and Resources | February 23, 2026 | Cuttsy + Cuttsy

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Press Releases | February 23, 2026 | Cuttsy + Cuttsy

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...

#ShortenTheJourney

Press Releases | February 18, 2026 | Medscape Education

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

Press Releases | February 18, 2026 | Medscape Education

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...

Winning in Pharma: the power of early strategic planning with patients

White Papers and Resources | February 17, 2026 | Amiculum

By Zoë van Helmond